Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for. 10x Genomics missed analysts’ revenue expectations by 5% last quarter ...

Wall Street analysts expect 10x Genomics (TXG) to post quarterly loss of $0.32 per share in its upcoming report, which indicates a year-over-year increase of 22%. Revenues are expected to be $158. ...

PGA Tour 2K25 is a beautiful upgrade on its predecessor and while it will have you sinking hours into virtual rounds of golf, it isn’t a complete hole-in-one just yet.

But did you? Rule 6.5 in the Rules of Golf covers all the action that just took place. If you unknowingly hole out and play another ball, or 10 more balls for that matter, and then discover you ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The company’s shares closed yesterday at $11.94.

You've probably seen golf tournaments on TV where a player opts to hit a shot off a paved cart path or has to stand on the cement because the lie is better than if the golfer took relief from the ...

In trading on Monday, shares of 10x Genomics Inc (Symbol: TXG) entered into oversold territory, hitting an RSI reading of 27.9, after changing hands as low as $11.8955 per share. By comparison ...

10x Genomics Price Performance Shares of TXG opened at $12.31 on Tuesday. The firm has a market cap of $1.49 billion, a PE ratio of -8.05 and a beta of 1.85. The stock’s fifty day moving average ...